The prestigious British Medical Journal (BMJ) is calling for the immediate release of COVID jab raw data.
In an article published on 19 January, Chief Editor Dr. Peter Doshi called the delay in releasing the data ‘unacceptable’, and reminiscent of the Tamiflu saga a decade earlier, where governments stock-piled billions of dollars of the drug which was later found to be useless.
In the case of the Pfizer COVID ‘vaccine’, Doshi wrote:
‘Pfizer’s pivotal covid vaccine trial was funded by the company and designed, run, analysed, and authored by Pfizer employees. The company and the contract research organisations that carried out the trial hold all the data. And Pfizer has indicated that it will not begin entertaining requests for trial data until May 2025, 24 months after the primary study completion date, which is listed on ClinicalTrials.gov as 15 May 2023.’
AstraZeneca and Moderna were no better, with the former saying it could take up to one year from a request for the data to be released, while the latter says data ‘may be’ available in 2022.
The same issues were faced with approved COVID therapeutic medications, such as Regeneron, where such data will simply not be made available to others.
While recent court orders in the US requiring the release of the documents were a step in the right direction, they may not be enough, because:
‘anyone looking for participant level datasets may be disappointed because Health Canada and the EMA do not receive or analyse these data, and it remains to be seen how the FDA responds to the court order. Moreover, the FDA is producing data only for Pfizer’s vaccine; other manufacturers’ data cannot be requested until the vaccines are approved, which the Moderna and Johnson & Johnson vaccines are not. Industry, which holds the raw data, is not legally required to honour requests for access from independent researchers.’
Doshi concludes:
‘Pharmaceutical companies are reaping vast profits without adequate independent scrutiny of their scientific claims. The purpose of regulators is not to dance to the tune of rich global corporations and enrich them further; it is to protect the health of their populations. We need complete data transparency for all studies, we need it in the public interest, and we need it now.’
Tomorrow there will be 4 mainstream media articles about why Peter Doshi is apparently a menace to public health and how the British Medical Journal is now a bastion of racism.